Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Want to see HK:2096 full AI Analyst Report?
Total Valuation
Simcere Pharmaceutical Group Limited has a market cap or net worth of HK$30.50B. The enterprise value is HK$24.16B.
Market CapHK$30.50B
Enterprise ValueHK$24.16B
Share Statistics
Simcere Pharmaceutical Group Limited has 2,595,697,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,595,697,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Simcere Pharmaceutical Group Limited’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.69%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)8.69%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.14M
Profits Per Employee230.00K
Employee Count6,584
Asset Turnover0.51
Inventory Turnover2.35
Valuation Ratios
The current PE Ratio of Simcere Pharmaceutical Group Limited is 9.3. Simcere Pharmaceutical Group Limited’s PEG ratio is 0.25.
PE Ratio9.3
PS Ratio3.54
PB Ratio2.83
Price to Fair Value2.83
Price to FCF23.17
Price to Operating Cash Flow21.76
PEG Ratio0.25
Income Statement
In the last 12 months, Simcere Pharmaceutical Group Limited had revenue of 7.53B and earned 1.31B in profits. Earnings per share was 0.53.
Revenue7.53B
Gross Profit6.15B
Operating Income1.22B
Pretax Income1.48B
Net Income1.31B
EBITDA1.60B
Earnings Per Share (EPS)0.53
Cash Flow
In the last 12 months, operating cash flow was 1.18B and capital expenditures -343.50M, giving a free cash flow of 835.41M billion.
Operating Cash Flow1.18B
Free Cash Flow835.41M
Free Cash Flow per Share0.32
Dividends & Yields
Simcere Pharmaceutical Group Limited pays an annual dividend of HK$0.175, resulting in a dividend yield of 1.36%
Dividend Per ShareHK$0.175
Dividend Yield1.36%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.57
52-Week Price Change38.56%
50-Day Moving Average12.34
200-Day Moving Average12.57
Relative Strength Index (RSI)66.24
Average Volume (3m)9.82M
Important Dates
Simcere Pharmaceutical Group Limited upcoming earnings date is Mar 31, 2023, TBA (Confirmed).
Last Earnings DateAug 31, 2022
Next Earnings DateMar 31, 2023
Ex-Dividend Date―
Financial Position
Simcere Pharmaceutical Group Limited as a current ratio of 2.21, with Debt / Equity ratio of 12.71%
Current Ratio2.21
Quick Ratio2.03
Debt to Market Cap0.04
Net Debt to EBITDA-1.48
Interest Coverage Ratio13.12
Taxes
In the past 12 months, Simcere Pharmaceutical Group Limited has paid 165.91M in taxes.
Income Tax165.91M
Effective Tax Rate0.11
Enterprise Valuation
Simcere Pharmaceutical Group Limited EV to EBITDA ratio is 15.25, with an EV/FCF ratio of 21.13.
EV to Sales3.23
EV to EBITDA15.25
EV to Free Cash Flow21.13
EV to Operating Cash Flow12.08
Balance Sheet
Simcere Pharmaceutical Group Limited has HK$3.62B in cash and marketable securities with HK$1.20B in debt, giving a net cash position of HK$2.42B billion.
Cash & Marketable SecuritiesHK$3.62B
Total DebtHK$1.20B
Net CashHK$2.42B
Net Cash Per ShareHK$0.93
Tangible Book Value Per ShareHK$3.16
Margins
Gross margin is 81.61%, with operating margin of 16.26%, and net profit margin of 17.38%.
Gross Margin81.61%
Operating Margin16.26%
Pretax Margin19.59%
Net Profit Margin17.38%
EBITDA Margin21.18%
EBIT Margin16.26%
Analyst Forecast
The average price target for Simcere Pharmaceutical Group Limited is HK$18.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$18.67
Price Target Upside35.39% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast16.62%
EPS Growth Forecast86.93%